Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 297-303

  Kaito, Ken ^a,b   Kobayashi, Masayuki ^a   Katayama, Toshio ^a   Masuoka, Hidekazu ^a   Shimada, Takaki ^a   Nishiwaki, Kaichi ^a   Sekita, Toru ^a   Otsubo, Hiroko ^a   Ogasawara, Yoji ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aplastic anaemia; Cyclosporine; G CSF; MDS; Monosomy 7

Indexed keywords

ANABOLIC AGENT; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CHROMOSOMES, HUMAN, PAIR 7; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MONOSOMY; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 7844223622     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01014.x     Document Type: Article

References (35)

1. Appelbaum, F.R., Barral, J., Storb, R., Ramberg, R., Doney, K., Sale, G.E. & Thomas, E.D. (1987) Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Experimental Hematology, 15, 1134-1139.
2. Bacigalupo, A., Broccia, G., Corda, G., Arcese, W., Carotenuto, M., Gallamini, A., Locatelli, F., Mori, P.G., Saracco, P., Todeschini, G., Coser, P., Iacopino, P., van Lint, M.T. & Gluckman, E. (1995) Antilymphocytc globulin, cyclosporin and granulocyte colonystimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA working party. Blood, 85, 1348-1353.
3. Barrios, N.J., Kirkpatrick. D.V., Levin, M.I., & Varela, M. (1991) Transient expression of trisomy 21 and monosomy 7 following cyclosporin A in a patient with aplastic anemia. Leukemia Research, 15, 531-533.
4. Camitta, B.M., Storb, R. & Thomas, E.D. (1982) Aplastic anemia: pathogenesis, diagnosis, treatment, and prognosis. New England Journal of Medicine, 306, 645-652.
5. Dale, D.C., Bonilla, M.A., Davis, M.W. Nakanishi, A.M., Hammond, W.P., Kurtzberg, J., Wang, W., Jakubowski, A., Winton, E., Lalezari, P., Robinson, W., Glaspy, J.A., Emerson, S., Gabrilove, J., Vincent, M. & Boxer, L.A. (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood, 81, 2496-2502.
6. De Planque, M.M., Bacigalupo, A., Wursch, A., Hows, J.M., Devergie, A., Frickhofen, N., Brand, A. & Nissen, C. (1989) Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. British Journal of Heamatology, 73, 121-126.
7. De Planque, M.M. Kluin-Nelemans, H.C., van Krieken, H.J.M., Kluin, P.M., Brand, A., Beverstock, G.C., Willemze, R. & van Rood, J.J. (1988) Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. British Journal of Haematology, 70, 55-62.
8. Doney, K., Pepe, M., Storb, R., Bryant, L., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Sanders, J., Singer, J., Sullivan, K., Weiden, P. & Hansen, J.A. (1992) Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG. very high-dose methylprednisolone, and oxymetholone. Blood, 79, 2566-2571.
9. Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, E., Freund, M., Meusers, P., Salama, A. & Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. New England Journal of Medicine, 324, 1297-1304.
10. Gabrilove, J. (1992) The development of granulocyte colonystimulating factor in its various clinical applications. Blood, 80, 1382-1385.
11. Gerritsen, W.R., Donohue, J., Bauman, J., Jhanwar, S.C., Kernan, N.A., Castro-Malaspina, H. O'Reilly, R.J. & Bourhis, J.H. (1992) Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by Iluorescent in situ hybridization. Blood, 80, 217-224.
12. Imashuku, S., Hibi, S., Kataoka, M.Y., Yoshihara, T., Ikushima, S., Morioka, Y. & Todo, S. (1995) Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia. British Journal of Haematology, 89, 188-190.
13. International Agranulocytosis and Aplastic Anemia Study (1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood, 70, 1718-1721.
14. Josten, K.M., Tooze, J.A., Borthwick-Clarke, C., Gordon-Smith, E.C. & Rutherford, T.R. (1991) Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood, 78, 3162-3167.
15. Kaito, K., Otsubo, H., Ogasawara, Y., Sekita, T., Saeki, A., Nishiwaki, K., Masuoka, U., Shimada, T., Kobayashi, M. & Sakai, O. (1995) RAEB in T with monosomy 7 after treatment of severe aplastic anemia with long term G-CSF. Japanese Journal of Clinical Hematology, 36, 365-370.
16. Kere, J., Ruutu, T, Davis, K.A., Roninson, I.B., Watkins, P.C., Winqvist, R. & de la Chapelle, A. (1989) Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood, 73, 230-234.
17. Kojima, S., Fukuda, M., Miyajima, Y., Matsuyama, T. & Horibe, K. (1991) Treatment of aplastic anemia with recombinant human granulocyte colony-stimulating factor. Blood, 77, 937-941.
18. Kojima, S., Tsuchida, M. & Matsuyama, T. (1992) Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. New England Journal of Medicine, 326, 294-1295.
19. Leonard, E.M., Raefsky, K., Griffith, P., Kimball, J., Nienhuis, A.W. & Young, N.S. (1989) Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. British Journal of Haematology, 72, 278-284.
20. Luna-Fineman, S., Shannon, K.M. & Lange, B.J. (1995) Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood, 85, 1985-1999.
21. Marsh, J.C.W. & Geary, C.G. (1991) Is aplastic anaemia a preleukaemic disorder? British Journal of Haematology, 77, 447-452.
22. Neuman, W.L., Rubin, C.M., Rios, R.B., Larson, R.A., Le Beau, M.M., Rowley, J.D., Vardiman, J.W., Schwarte, J.L. & Farber, R.A. (1992) Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood, 79, 1501-1510.
23. Ohara, A., Kojima, S., Hamajima, N., Tsuchida, M., Imashuku, S., Ohta, S., Sasaki, H., Okamura, J., Sugita, K., Kitagawa, H., Kiriyama, Y., Akatsuka, J. & Tsukimoto, I. (1997) Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood, 90, 1009-1013.
24. Paquette, R.L., Tebyani, N., Frane, M., Ireland, P., Ho, W.G., Champlin, R.E. & Nimer, S.D. (1995) Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood, 85, 283-290.
25. Passweg, J.R., Socie, G., Hinterberger, W., Biacigalupo, A., Biggs, J.C., Camitta, B.M., Champlin, R.B., Gale, R.P. Gluckman, E., Gordon-Smith, E.C., Hows, J.M., Klein, J.P., Nugent, M.L., Pasquini, R., Rowlings, P.A., Speck, B., Tichelli, A., Zhang, M.J., Horowitz, M.M. & Bortin, M.M. (1997) Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood, 90, 858-864.
26. Rosenfeld, S.J., Kimball, J., Vining, D. & Young, N.S. (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood, 85, 3058-3065.
27. Schubert, J., Vogt, H.G., Zielinska-Skowronek, M., Freund, M., Kaltwasser, J.P., Hoelzer, D. & Schmidt, R.E. (1994) Development of the glycosylphosphatitylinositol-anchoring defect characteristes for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood, 83, 2323-2328.
28. Scopes, J., Daly, S., Atkinson, R., Ball, S.E., Gordon-Smith, E.C. & Gibson, F.M. (1996) Aplastic anemia: evidence for dysfunctional bone marrow progenitor cells and the corrective effect of granulocyte colony-stimulating factor in vitro. Blood, 87, 3179-3185.
29. Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Veer-Korthof, E.V. & Gluckman, E. (1995) Malignant tumors occurring after treatment of aplastic anemia. New England Journal of Medicine. 329, 1152-1157.
30. Tichelli, A., Gratwohl, A., Wursch, A., Nissen, C. & Speck, B. (1988) Late haematological complications in severe aplastic anaemia. British Journal of Haematology, 69, 413-418.
31. Tuzuner, N., Cox, C., Rowe, J.M., Watrous, D. & Bennett, J.M. (1995) Hypocellular myelodysplastic syndrome (MDS): new proposals. British Journal of Haematology, 91, 612-617.
32. Van Kamp, H., Landegent, J.E., Jansen, R.P.M., Willemze, R. & Fibbe, W.E. (1991) Clonal hematopoiesis in patients with acquired aplastic anemia. Blood, 78, 3209-3214.
33. Viguie, F., Prigent, Y., Ramond, S., Baumelou, E., Cadiou, M., Dreyfus, R & Zittoun, R. (1995) Fluorescent in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7. Leukemia, 9, 1154-1158.
34. Virjee, S. & Ballon, C. (1996) Hypoplastic myelodysplasia (MDS). British Journal of Haematology, 94, 582.
35. Young, N.S. (1992) The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood, 79, 1385-1392.